Celgene Corporation to Present at the Oppenheimer & Co. Inc. 20th Annual Healthcare Conference
Business Wire
Oct 30, 2009
Celgene Corporation (NASDAQ: CELG) today announced its
presentation at the Oppenheimer & Co. Inc. 20th Annual
Healthcare Conference on Wednesday, November 4, 2009 at 10:15 a.m. ET
will be webcast live and will be available in the investor relations
section of the company’s Web site at www.celgene.com.
Celgene management will provide an overview of the company.
Celgene Corporation, headquartered in Summit, New Jersey, is an
integrated global biopharmaceutical company engaged primarily in the
discovery, development and commercialization of novel therapies for the
treatment of cancer and inflammatory diseases through gene and protein
regulation. For more information, please visit the company’s Web site at www.celgene.com.
This release contains certain forward-looking statements which
involve known and unknown risks, delays, uncertainties and other factors
not under the Company's control, which may cause actual results,
performance or achievements of the Company to be materially different
from the results, performance or other expectations implied by these
forward-looking statements. These factors include results of current or
pending research and development activities, actions by the FDA and
other regulatory authorities, and those factors detailed in the
Company's filings with the Securities and Exchange Commission such as
10K, 10Q and 8K reports.
(c) 2009 Business Wire, Inc., All rights reserved. All of the news releases and other content contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. Any copying or reproduction (other than for an individual user's personal reference), redistribution, reposting or other transmission or communication is expressly prohibited without prior written permission of Business Wire, Inc
